Key points are not available for this paper at this time.
The field of cardiogenic shock (CS) has advanced rapidly in recent years, in part due to the creation and widespread adoption of the Society for Cardiovascular Angiography & Interventions (SCAI) SHOCK Classification in 2019, subsequently refined in 2022.1,2 As investigators adopted the classification and expanded research into the field, some themes have emerged. First, diagnosing and staging CS has become the cornerstone of management, inclusive of using the SCAI SHOCK stage trajectory. Second, CS teams are vital to the consistency of management, providing both experience and expertise, as well as checks and balances on individual patients and system-based care.
Naidu et al. (Tue,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: